DETERMINATION OF RAND DENOMINATED SUBSCRIPTION CONSIDERATION IN TERMS OF THE PRIVATE PLACEMENT
Private placement applicants are referred to the RNS announcement of the Company released earlier today, in terms of which the Company advised that it successfully placed a total of 105,263,158 ordinary shares ("Private Placement Shares"), representing 20% of the Company's current issued share capital (excluding treasury shares), of which 90,008,658 Private Placement Shares were placed on the South African register and the balance onto the United Kingdom register at an issue price of €0.38 cents per share, for an aggregate subscription amount of €40 million.
Private placement applicants that will subscribe for shares on the South African register are hereby advised that the exchange rate for the determination of your Rand denominated subscription consideration shall beZAR13.74:EUR1, being the closing ZAR:EUR exchange rate, as quoted by Bloomberg, at 17:00 (CAT)today, 28 November 2014.
Guernsey
28 November 2014
Transaction adviser, sole bookrunner and sponsor in relation to the listing on AltX and the Private Placement in South Africa: PSG Capital (Pty) Ltd
Sole bookrunner and nomad in relation to the AIM Rules and private placing in the UK: Peel Hunt
Legal Adviser as to English and South African law: Norton Rose Fulbright
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.